JTT-608 restores impaired early insulin secretion in diabetic Goto-Kakizaki rats.
about
Enhanced exercise-induced muscle damage and muscle protein degradation in streptozotocin-induced type 2 diabetic rats.The insulinotropic mechanism of the novel hypoglycaemic agent JTT-608: direct enhancement of Ca(2+) efficacy and increase of Ca(2+) influx by phosphodiesterase inhibition.Beneficial effect of T-1095, a selective inhibitor of renal Na+-glucose cotransporters, on metabolic index and insulin secretion in spontaneously diabetic GK rats.Daily inhibition of postprandial hyperglycaemia with JTT-608, a novel oral antidiabetic agent, ameliorates pancreatic function in neonatally streptozotocin-treated rats.
P2860
JTT-608 restores impaired early insulin secretion in diabetic Goto-Kakizaki rats.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
JTT-608 restores impaired early insulin secretion in diabetic Goto-Kakizaki rats.
@en
JTT-608 restores impaired early insulin secretion in diabetic Goto-Kakizaki rats.
@nl
type
label
JTT-608 restores impaired early insulin secretion in diabetic Goto-Kakizaki rats.
@en
JTT-608 restores impaired early insulin secretion in diabetic Goto-Kakizaki rats.
@nl
prefLabel
JTT-608 restores impaired early insulin secretion in diabetic Goto-Kakizaki rats.
@en
JTT-608 restores impaired early insulin secretion in diabetic Goto-Kakizaki rats.
@nl
P2093
P2860
P356
P1476
JTT-608 restores impaired early insulin secretion in diabetic Goto-Kakizaki rats
@en
P2093
P2860
P304
P356
10.1038/SJ.BJP.0702481
P407
P50
P577
1999-04-01T00:00:00Z